Test Price
2,400 AED✅ Home Collection Available
Microarray 60K (POC) + Couple Karyotyping in UAE | 2400 AED | DHA Guidelines
Executive Summary & Core Metrics
This advanced cytogenetic panel analyzes the genetic integrity of products of conception (POC) using a high-resolution 60,000-marker chromosomal microarray (Agilent) in parallel with parental blood karyotyping. It uncovers the underlying cause of recurrent pregnancy loss and guides future reproductive decisions. The test offers 99.9% analytical sensitivity for copy number variants and chromosomal imbalances, supported by an ISO 9001:2015 accredited laboratory.
7–9 Days
2,400 AED
CMA + Karyotyping
DHA 1143
Test Overview & Methodology
This combined assay integrates chromosomal microarray (CMA) with traditional G-banded karyotyping to deliver comprehensive genetic analysis for recurrent pregnancy loss. CMA detects submicroscopic copy number variants (CNVs) from 200 kb resolution, while parental karyotyping identifies balanced structural rearrangements such as translocations and inversions. The parallel workup yields a diagnostic rate exceeding 99% for cytogenetic abnormalities implicated in miscarriage.
| Test Component | Our Advanced Panel | Conventional Karyotyping Only |
|---|---|---|
| Resolution | 60,000 probes (CNVs ≥200 kb) + G‑banding (5–10 Mb) | G‑banding only (~5 Mb) |
| Methodology | Chromosomal Microarray (CMA, Agilent) with cell culture karyotyping | Cell culture + G‑banding |
| Turnaround Time | 7–9 days (both results) | 14–21 days |
| Detection Scope | Copy number variants, aneuploidy, uniparental disomy, triploidy, and balanced rearrangements in parents | Major aneuploidies and large structural rearrangements |
Physician Insight & Safety Protocols
“I understand how emotionally taxing recurrent pregnancy loss can be. This combined test not only clarifies the genetic contribution but empowers couples with a clear reproductive plan. A normal result is equally reassuring, and abnormal findings allow for targeted interventions. Always interpret results in the context of your full medical history.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Medication Advisory
Do not discontinue any prescribed medication, including hormonal support or anticoagulants, without direct approval from your treating physician. The test does not replace ongoing clinical management.
Exclusion Criteria & ER Red Flags
- POC sample that is macerated, contaminated, or of insufficient quantity (consult collection guidelines).
- Parental blood samples drawn within 2 weeks of recent blood transfusion or bone marrow transplant (may cause chimerism).
- If the mother experiences heavy bleeding, severe abdominal pain, or signs of infection post‑procedure, seek emergency care immediately.
Patient FAQ & Clinical Guidance
1. How does the combined microarray and karyotyping improve diagnosis over a single test?
Microarray detects submicroscopic gains/losses down to 200 kb while parental karyotyping identifies balanced rearrangements, together delivering >99% diagnostic yield for recurrent pregnancy loss.
2. What does the 7–9 day TAT include, and can I get preliminary results sooner?
This timeframe covers tissue culture, DNA extraction, microarray scanning, and parental karyotyping with full interpretation. Preliminary verbal results are available from day 5.
3. Is home collection available for both the POC sample and parental blood?
Parental blood can be collected at home via our VIP mobile phlebotomy service (8 AM – 11 PM daily). The POC tissue sample requires hospital extraction only – our medical courier retrieves it from your hospital under strict cold-chain protocol; mobile home phlebotomy is disabled for safety.
UAE Regulatory & Data Privacy Adherence
All processing adheres to Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent are governed by Federal Decree-Law No. 4 of 2016 on Medical Liability. The laboratory is licensed by the Dubai Health Authority (DHA License No. 1143) and accredited to ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139).
Clinical & Logistical Metadata
| Test Name | Microarray 60K (POC) + Couple Karyotyping |
| Price (AED) | 2,400 |
| Turnaround Time | 7–9 days |
| Sample Type / Matrix | Products of conception tissue (hospital extraction only) + Parental whole blood (VIP mobile phlebotomy available) |
| Methodology Used | Chromosomal Microarray (Agilent 60K) + G‑banded Karyotyping |
| ICD-10-CM Code | N96 (Recurrent pregnancy loss) |
| LOINC Code | 81278-6 (Chromosomal microarray analysis) |
| DHA Facility License & Address | License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians